Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CALA | US
-0.00
-50.00%
Healthcare
Biotechnology
31/12/2022
21/10/2024
0.00
0.00
0.00
0.00
Calithera Biosciences Inc. operates under a plan of liquidation that was approved in January 2023. Previously the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences Inc. was incorporated in 2010 and is headquartered in South San Francisco California.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
458.3%1 month
17651.5%3 months
7857.0%6 months
6013.7%-
-
0.07
0.08
0.06
0.18
0.01
-0.29
-41.82M
4.87K
4.87K
-
-
-
-
-114.14
0.78
8.92
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.00
Range1M
0.03
Range3M
0.05
Rel. volume
0.08
Price X volume
0.55
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
XOMAP | XOMAP | Biotechnology | 26.24 | 0 | -0.23% | 26.27 | 121.93% |
XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.5992 | 0 | 0.02% | 25.57 | 121.93% |
SABSW | SABSW | Biotechnology | 0.0534 | 0 | 8.54% | 0.17 | 11.58% |
Revolution Medicines Inc. Warrant | RVMDW | Biotechnology | 0.1195 | 0 | 18.32% | n/a | 5.40% |
REVBW | REVBW | Biotechnology | 0.0129 | 0 | -3.01% | n/a | 0.00% |
Rocket Pharmaceuticals Inc. Warrant | RCKTW | Biotechnology | 0.0666 | 0 | -6.06% | n/a | 0.00% |
OCEAW | OCEAW | Biotechnology | 0.0398 | 0 | 2.58% | n/a | -16.02% |
Nutriband Inc. Warrant | NTRBW | Biotechnology | 1.15 | 0 | 9.52% | n/a | 1.72% |
NKGen Biotech Inc. Warrants | NKGNW | Biotechnology | 0.032 | 0 | 29.03% | n/a | -40.33% |
JSPRW | JSPRW | Biotechnology | 0.21 | 0 | 0.00% | n/a | 2.31% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.18 | 0.53 | Cheaper |
Ent. to Revenue | 0.01 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 0.07 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 7,857.01 | 72.80 | Riskier |
Debt to Equity | 0.08 | -1.23 | Expensive |
Debt to Assets | 0.06 | 0.25 | Cheaper |
Market Cap | 4.87K | 3.66B | Emerging |